[Marginal - donor and recipient].
A significant gap exists between organ supply and demand in the world. Marginal donors have been accepted as organ donors in recent years. On the other hand, aging recipients and recipients with complications have increased. This symposium was organized to discuss marginal donors and high risk recipients. We discussed fundamental researches such as prevention of renal ischemia reperfusion injury by erythropoitin and hepatocyte growth factor-macrophage stimulating protein (HGF-MSP) chimera, and the acquired tolerance induction using the CD28 superagonist antibody. We believe that this discussion will help increase the number of cadaveric kidney transplantations and improve the treatment outcome.